Consultez notre page spéciale COVID-19 pour connaître les marchés liés aux besoins en matériel médical.
231901-2021 - Belgique-Bruxelles: Production, options d’achat prioritaires et fourniture de vaccins contre la Covid-19, y compris les vaccins adaptés aux variantes du SRAS-CoV-2 et les formules pédiatriques de tels vaccins pour les États membres de l’UE
Royaume-Uni-Birmingham: Appareils d'endoscopie et d'endochirurgie
Avis de marché
Section I: Pouvoir adjudicateur
Section II: Objet
Framework for the Supply of Endoscopy Consumables and Associated Products
HealthTrust Europe is looking to establish a framework agreement for the provision of endoscopy consumables and associated products, used in bronchoscopy, gastroscopy, colonoscopy and ERCP. The framework will cover a comprehensive range of products to include but not limited to, balloons, biliary ERCP, biopsy, catheters, cannulae, capsules/pill camera, cleaning equipment, clips, cytology brushes, dilatation, endoscopic ultra sound (EUS), enteral feeding, forceps, guidewires, haemostasis, ligators, metal stents, needles, plastic stents, snares, sphincterotomes and accessories.
There is a requirement for suppliers to provide ongoing product training and clinical support throughout the lifetime of the contract, to ensure safe, appropriate and effective use of products by clinical persons.
12 months additional period at the discretion of HealthTrust Europe.
Section III: Renseignements d’ordre juridique, économique, financier et technique
HTE may request such information as may be requested pursuant to Regulation 58 of the Public Contracts Regulations 2015. Details are provided in the standard selection questionnaire ‘SQ’.
Section IV: Procédure
Section VI: Renseignements complémentaires
HTE is a central purchasing body who is able to carry out this tender exercise by virtue of its appointment as an agent of UHCW. Notwithstanding HTE’s relationship with UHCW, it is HTE conducting this tender exercise and will execute the resultant framework agreement with successful bidders. The bodies to whom the use of this framework agreement will be open include all contracting authorities in the UK as defined in Regulation
Two of the Public Contracts Regulations 2015 as may be updated from time to time. In particular, the following entities in the UK (particularly those of a health and/or social care nature) are envisaged as framework agreement users:
1) all National Health Service (NHS) bodies in England, including but not limited to:
(i) acute trusts (as listed at: http://www.nhs.uk/servicedirectories/pages/acutetrustlisting.aspx),
(ii) health and care trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx),
(iii) mental health trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/MentalHealthTrustListing.aspx),
(iv) clinical commissioning groups (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx),
(v) ambulance trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx),
(vi) area teams (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx),
(vii) special health authorities (http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx),
(viii) NHS England, and
(ix) clinical senates and strategic clinical networks;
2) all NHS bodies in Wales, including but not limited to all:
(i) health boards,
(ii) NHS trusts,
(iii) the national delivery group,
(iv) community health councils, and
(v) NHS Wales shared services partnership (as listed at http://www.wales.nhs.uk/nhswalesaboutus/structure);
3) all NHS bodies in Northern Ireland (known as Health and Social Care), including but not limited to:
(i) health and social care trusts (as listed at: http://online.hscni.net/?s=Trust),
(ii) health agencies (as listed at: http://online.hscni.net/?s=health+agencies),
(iii) hospitals (as listed at: http://online.hscni.net/?s=hospitals), and
(iv) the Health and Social Care Board;
4) social enterprises undertaking some or all of the previous service provider functions of contracting authorities in relation to health and/or social care services (including charitable incorporated organisations, cooperatives, industrial and provident societies and community interest companies listed on the Companies House WebCheck service);
5) ministerial departments and non-ministerial departments of central government, non-departmental agencies and other public bodies and public corporations (as listed at: https://www.gov.uk/government/organisations);
6) devolved governmental and parliamentary organisations within the UK, including but not limited to the Scottish Government, Scottish Parliament and Scottish public bodies (as listed at: http://www.scotland.gov.uk/Topics/Government/public-bodies/about/Bodies), as well as the Welsh Government, Welsh Assembly and Welsh unitary authorities (as listed at: http://www.assembly.wales/en/abthome/role-of-assembly-howitworks/Pages/governance-of-wales.aspx);
7) all local authorities (as listed at: http://local.direct.gov.uk/LDGRedirect/Start.do?mode=1);
8) the Ministry of Defence (as detail:https://www.gov.uk/government/organisations/ministry-of-defence).
This list includes each organisation’s successors and assigns, any equivalent organisations and associated organisation created due to any organisational changes. This framework agreement will be open to any bodies or organisations operating in the UK of a health, and/or social care nature or which have a similar procurement need and/or any UK based central government authority listed at Annex I of Directive 2014/24/EU, in respect of any goods or services to any of the above-listed organisation.
HTE will incorporate a standstill period at the point information on the award of the contract is communicated to tenders. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderer to challenge the award decision before the contract is entered into.